Expressions of interest sought for trade mission to UK
Tuesday, 17 August, 2004
Expressions of interest are being sought from Australian biotechnology companies interested in joining a trade mission to the United Kingdom and BioPartnering Europe 2004.
The mission, which will include 15 Australian biotechnology companies, is being put together by UK Trade and Investment and Austrade, and follows on from a pilot program last year, which saw a dozen Victorian companies tour several biotech clusters in the UK.
The companies will attend a partnering program in the Scandinavian biotech cluster Medicon Valley, prior to participating in BioPartnering Europe 2004 in London from 10-12 October.
After the partnering conference, the delegates will be matched up with British companies in a special partnering session, which will also involve a number of other countries including New Zealand, France and Israel.
"Last year we took the companies all over the countryside to various biotech locations, but this year the British companies chosen to meet with the Australian delegates will come to London," said Rob Hemming, trade development manager at the British Consulate-General in Melbourne and joint leader of the Australian delegation with the BioMelbourne Network's Tim Murphy.
The cost of the mission will be borne by UK Trade and Investment, Austrade, and state governments.
"There is no direct cost for companies to participate in the program," Murphy said.
Companies interested in going should be working in one or more of the following areas: genomics, biomanufacturing, neuroscience, structural biology, metabolic disorders, agbio, medical devices, stem cells, infectious diseases, oncology, vaccines and clinical trials.
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
